Abstract
At present, neurostimulation methods in pain management have the greatest benefit and benefit for patients suffering from pharmacologically-resisting chronic pain. In the future, it is possible to assume that neurostimulation methods will not be indicated until all therapies have been exhausted, but instead they will be at the top of the ranking list.
Chronic pain occurs in up to 30% of the adult population, although some authors present a lower figure of about 10%, while others suggest that it could be up to 50% prevalence, especially in developed countries. Neurostimulation methods are mainly used for drug-resistant chronic pain where long-term treatment is ineffective.
In patients with chronic neuropathic pain lasting longer than 6 months, and usually refractory and well-established analgesic therapy (first and second treatment ineffectiveness and / or unacceptable side effects), it is advisable to consider interventional techniques such as invasive or non-invasive neurostimulation.